Ramraj, Satish K <br/><br/>
Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53.  [electronic resource] 

 -  International journal of cancer  08 2020 
 - 1086-1097 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.32830  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Aza Compounds--pharmacology<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Cell Line, Tumor<br/>Chromans--pharmacology<br/>Female<br/>HSP70 Heat-Shock Proteins--antagonists & inhibitors<br/>Humans<br/>Maintenance Chemotherapy--methods<br/>Mice, Nude<br/>Molecular Targeted Therapy--methods<br/>Mutation<br/>Ovarian Neoplasms--drug therapy<br/>Thiones--pharmacology<br/>Tumor Suppressor Protein p53--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays--methods